Blog: ODYSSEY HEALTH, INC. : Other Events, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) –

Item 8.01 Other Material Event

May 5, 2022, Odyssey Health, Inc. (OTC:ODYY), f/k/a Odyssey Group International,
Inc., a company focused on developing unique, life-saving medical products,
announced positive results from the first group of patients dosed with PRV-002,
in their Phase I clinical trial. Odyssey’s trial is administering PRV-002, their
novel drug to treat concussion, to healthy human subjects.

Item 7.01 Regulation FD Disclosure

Attached is a copy of a press release being issued by the Company relating to
the above-referenced matter, a copy of which is attached as Exhibit as 99.1 and
is hereby incorporated.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Number       Exhibit
99.1           Press Release
104          Cover Page Interactive Data File (embedded within the Inline XBRL

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s